Publications

Filter
Article
Article

A phase 1b/II study of cancer stemness inhibitor napabucasin in combination with gemcitabine (gem) & nab-paclitaxel (nabptx) in metastatic pancreatic adenocarcinoma (mpdac) patients (pts)

Bekaii-Saab, T., Starodub, A., El-Rayes, B., O'Neil, B., Shahda, S., Ciombor, K., Noonan, A., Hanna, W., Sehdev, A., Shaib, W., Mikhail, S., Neki, A., Oh, C., Li, Y. Z., Li, W., Borodyansky, L. & Li, C. J., Jun 1 2017, In : Annals of oncology : official journal of the European Society for Medical Oncology. 28, p. iii150

Research output: Contribution to journalArticle

Open Access
7 Scopus citations

A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma

Chiorean, E. G., Dragovich, T., Hamm, J., Langmuir, V. K., Kroll, S., Jung, D. T., Colowick, A. B., Tidmarsh, G. F. & Loehrer, P. J., May 1 2008, In : Cancer Chemotherapy and Pharmacology. 61, 6, p. 1019-1026 8 p.

Research output: Contribution to journalArticle

13 Scopus citations

Aphase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Benson, D. M., Hofmeister, C. C., Padmanabhan, S., Suvannasankha, A., Jagannath, S., Abonour, R., Bakan, C., Andre, P., Efebera, Y., Tiollier, J., Caligiuri, M. A. & Farag, S. S., Nov 22 2012, In : Blood. 120, 22, p. 4324-4333 10 p.

Research output: Contribution to journalArticle

147 Scopus citations

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

Sharman, J. P., Wheler, J. J., Einhorn, L., Dowlati, A., Shapiro, G. I., Hilton, J., Burke, J. M., Siddiqi, T., Whiting, N. & Jalal, S. I., Aug 15 2019, In : Investigational New Drugs. 37, 4, p. 738-747 10 p.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations

A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitis

Ratziu, V., Sheikh, M. Y., Sanyal, A. J., Lim, J. K., Conjeevaram, H., Chalasani, N., Abdelmalek, M., Bakken, A., Renou, C., Palmer, M., Levine, R. A., Bhandari, B. R., Cornpropst, M., Liang, W., King, B., Mondou, E., Rousseau, F. S., Mchutchison, J. & Chojkier, M., Feb 1 2012, In : Hepatology. 55, 2, p. 419-428 10 p.

Research output: Contribution to journalArticle

110 Scopus citations

A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma

Tarhini, A. A., Millward, M., Mainwaring, P., Kefford, R., Logan, T., Pavlick, A., Kathman, S. J., Laubscher, K. H., Dar, M. M. & Kirkwood, J. M., Feb 15 2009, In : Cancer. 115, 4, p. 859-868 10 p.

Research output: Contribution to journalArticle

48 Scopus citations

A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma

Voss, M. H., Bhatt, R. S., Vogelzang, N. J., Fishman, M., Alter, R. S., Rini, B. I., Beck, J. T., Joshi, M., Hauke, R., Atkins, M. B., Burgess, E., Logan, T. F., Shaffer, D., Parikh, R., Moazzam, N., Zhang, X., Glasser, C., Sherman, M. L. & Plimack, E. R., Jul 15 2019, In : Cancer. 125, 14, p. 2400-2408 9 p.

Research output: Contribution to journalArticle

2 Scopus citations

A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis

Ejskjaer, N., Wo, J. M., Esfandyari, T., Mazen Jamal, M., Dimcevski, G., Tarnow, L., Malik, R. A., Hellström, P. M., Mondou, E., Quinn, J., Rousseau, F. & Mccallum, R. W., Feb 1 2013, In : Neurogastroenterology and Motility. 25, 2, p. e140-e150

Research output: Contribution to journalArticle

63 Scopus citations

A phase 2 multicenter study of tivantinib (ARQ 197) monotherapy in patients with relapsed or refractory germ cell tumors

Feldman, D. R., Einhorn, L. H., Quinn, D. I., Loriot, Y., Joffe, J. K., Vaughn, D. J., Fléchon, A., Hajdenberg, J., Halim, A. B., Zahir, H. & Motzer, R. J., Aug 1 2013, In : Investigational New Drugs. 31, 4, p. 1016-1022 7 p.

Research output: Contribution to journalArticle

37 Scopus citations

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14-179

Durm, G. A., Jabbour, S. K., Althouse, S. K., Liu, Z., Sadiq, A. A., Zon, R. T., Jalal, S. I., Kloecker, G. H., Williamson, M. J., Reckamp, K. L., Langdon, R. M., Kio, E. A., Gentzler, R. D., Adesunloye, B. A., Harb, W. A., Walling, R. V., Titzer, M. L. & Hanna, N. H., 2020, (Accepted/In press) In : Cancer. 126, 19, p. 4353-4361 9 p.

Research output: Contribution to journalArticle

A phase 2 trial of glufosfamide in combination with gemcitabine in chemotherapy-naive pancreatic adenocarcinoma

Chiorean, E. G., Dragovich, T., Hamm, J., Barrios, C. H., Gorini, C. F., Langmuir, V. K., Kroll, S., Jung, D. T., Tidmarsh, G. T. & Loehrer, P. J., Apr 2010, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 33, 2, p. 111-116 6 p.

Research output: Contribution to journalArticle

11 Scopus citations

A phased-array stimulator system for studying planar and curved cardiac activation wavefronts

Abbas, R. A., Lin, S. F., Mashburn, D., Xu, J. & Wikswo, J. P., Jan 1 2008, In : IEEE Transactions on Biomedical Engineering. 55, 1, p. 222-229 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-α2b in patients with solid tumors

Schneider, B., Fukunaga, A., Murry, D., Yoder, C., Fife, K., Foster, A., Rosenberg, L., Kelich, S., Li, L. & Sweeney, C., Feb 1 2007, In : Cancer Chemotherapy and Pharmacology. 59, 2, p. 261-268 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer

Morris, M. J., Eisenberger, M. A., Pili, R., Denmeade, S. R., Rathkopf, D., Slovin, S. F., Farrelly, J., Chudow, J. J., Vincent, M., Scher, H. I. & Carducci, M. A., Oct 2012, In : Annals of Oncology. 23, 10, p. 2714-2719 6 p., mds078.

Research output: Contribution to journalArticle

27 Scopus citations

A Phase I/II Dose-Escalation Trial of Bevacizumab in Previously Treated Metastatic Breast Cancer

Cobleigh, M. A., Langmuir, V. K., Sledge, G. W., Miller, K. D., Haney, L., Novotny, W. F., Reimann, J. D. & Vassel, A., Oct 2003, In : Seminars in oncology. 30, 5 SUPPL. 16, p. 117-124 8 p.

Research output: Contribution to journalArticle

427 Scopus citations

A Phase I and Pharmacokinetic Study of ILX-295501, an Oral Diarylsulfonylurea, on a Weekly for 3 Weeks Every 4-Week Schedule in Patients with Advanced Solid Malignancies

Forouzesh, B., Takimoto, C. H., Goetz, A., Diab, S., Hammond, L. A., Smetzer, L., Schwartz, G., Gazak, R., Callaghan, J. T., Von Hoff, D. D. & Rowinsky, E. K., Nov 15 2003, In : Clinical Cancer Research. 9, 15, p. 5540-5549 10 p.

Research output: Contribution to journalArticle

15 Scopus citations

A phase I and pharmacokinetic trial of erlotinib in combination with weekly docetaxel in patients with taxane-naive malignancies

Chiorean, E. G., Porter, J. M., Foster, A. E., Al Omari, A. S. H., Yoder, C. A., Fife, K. L., Strother, R. M., Murry, D. J., Yu, M., Jones, D. R. & Sweeney, C. J., Feb 15 2008, In : Clinical Cancer Research. 14, 4, p. 1131-1137 7 p.

Research output: Contribution to journalArticle

20 Scopus citations

A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors

Beatty, G. L., Shahda, S., Beck, T., Uppal, N., Cohen, S. J., Donehower, R., Gabayan, A. E., Assad, A., Switzky, J., Zhen, H. & Von Hoff, D. D., Jan 2019, In : Oncologist. 24, 1, p. 14-e10

Research output: Contribution to journalArticle

5 Scopus citations

A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors

Michaelson, M. D., Gupta, S., Agarwal, N., Szmulewitz, R., Powles, T., Pili, R., Bruce, J. Y., Vaishampayan, U., Larkin, J., Rosbrook, B., Wang, E., Murphy, D., Wang, P., Lechuga, M. J., Valota, O. & Shepard, D. R., Sep 1 2019, In : Oncologist. 24, 9, p. 1151-e817

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia

Lancet, J. E., Ravandi, F., Ricklis, R. M., Cripe, L. D., Kantarjian, H. M., Giles, F. J., List, A. F., Chen, T., Allen, R. S., Fox, J. A., Michelson, G. C. & Karp, J. E., Dec 2011, In : Leukemia. 25, 12, p. 1808-1814 7 p.

Research output: Contribution to journalArticle

37 Scopus citations

A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors

Chiorean, E. G., Malireddy, S., Younger, A. E., Jones, D. R., Waddell, M. J., Sloop, M. I., Yu, M., Hall, S. D., Schneider, B. & Sweeney, C. J., Aug 1 2010, In : Cancer Chemotherapy and Pharmacology. 66, 3, p. 441-448 8 p.

Research output: Contribution to journalArticle

7 Scopus citations

A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors

Jhaveri, K., Miller, K., Rosen, L., Schneider, B., Chap, L., Hannah, A., Zhong, Z., Ma, W., Hudis, C. & Modi, S., Sep 15 2012, In : Clinical Cancer Research. 18, 18, p. 5090-5098 9 p.

Research output: Contribution to journalArticle

41 Scopus citations

A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining

Wierzbicki, R., Jonker, D. J., Moore, M. J., Berry, S. R., Loehrer, P. J., Youssoufian, H. & Rowinsky, E. K., Feb 1 2011, In : Investigational New Drugs. 29, 1, p. 167-174 8 p.

Research output: Contribution to journalArticle

28 Scopus citations

A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer

Diamond, J. R., Eckhardt, S. G., Pitts, T. M., van Bokhoven, A., Aisner, D., Gustafson, D. L., Capasso, A., Sams, S., Kabos, P., Zolman, K., Colvin, T., Elias, A. D., Storniolo, A. M., Schneider, B. P., Gao, D., Tentler, J. J., Borges, V. F. & Miller, K. D., Aug 2 2018, In : Breast Cancer Research. 20, 1, 82.

Research output: Contribution to journalArticle

10 Scopus citations

A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma

Mayer, E. L., Demichele, A., Rugo, H. S., Miller, K., Waks, A. G., Come, S. E., Mulvey, T., Jeselsohn, R., Overmoyer, B., Guo, H., Barry, W. T., Huang Bartlett, C., Koehler, M., Winer, E. P. & Burstein, H. J., Sep 1 2019, In : Annals of Oncology. 30, 9, p. 1514-1520 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

A phase II Hoosier Oncology Group study of vinorelbine and estramustine phosphate in hormone-refractory prostate cancer

Sweeney, C. J., Monaco, F. J., Jung, S. H., Wasielewski, M. J., Picus, J., Ansari, R. H., Dugan, W. M. & Einhorn, L. H., Jul 10 2002, In : Annals of Oncology. 13, 3, p. 435-440 6 p.

Research output: Contribution to journalArticle

27 Scopus citations

A phase III, multicenter, prospective, single-blinded, noninferiority, randomized controlled trial on the performance of a novel esophageal stent with an antireflux valve (with video)

Dua, K. S., DeWitt, J. M., Kessler, W. R., Diehl, D. L., Draganov, P. V., Wagh, M. S., Kahaleh, M., Wong Kee Song, L. M., Khara, H. S., Khan, A. H., Aburajab, M. M., Ballard, D., Forsmark, C. E., Edmundowicz, S. A., Brauer, B. C., Tyberg, A., Buttar, N. S. & Adler, D. G., Jul 2019, In : Gastrointestinal endoscopy. 90, 1, p. 64-74.e3

Research output: Contribution to journalArticle

2 Scopus citations

A phase III randomized three-arm trial of physical therapist delivered pain coping skills training for patients with total knee arthroplasty: The KASTPain protocol

Riddle, D. L., Keefe, F. J., Ang, D., J, K., Dumenci, L., Jensen, M. P., Bair, M. J., Reed, S. D. & Kroenke, K., Aug 27 2012, In : BMC Musculoskeletal Disorders. 13, 149.

Research output: Contribution to journalArticle

30 Scopus citations

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

Rex, D. K., Bhandari, R., Desta, T., DeMicco, M. P., Schaeffer, C., Etzkorn, K., Barish, C. F., Pruitt, R., Cash, B. D., Quirk, D., Tiongco, F., Sullivan, S. & Bernstein, D., Sep 2018, In : Gastrointestinal endoscopy. 88, 3, p. 427-437.e6

Research output: Contribution to journalArticle

12 Scopus citations

A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease

Carpenter, P. A., Lowder, J., Johnston, L., Frangoul, H., Khoury, H., Parker, P., Jerome, K. R., McCune, J. S., Storer, B., Martin, P., Appelbaum, F., Abonour, R., Westervelt, P. & Anasetti, C., Jun 1 2005, In : Biology of Blood and Marrow Transplantation. 11, 6, p. 465-471 7 p.

Research output: Contribution to journalArticle

75 Scopus citations
19 Scopus citations

A phase II study of 13-cis retinoic acid plus interferon α-2a in advanced stage penile carcinoma: An Eastern Cooperative Oncology Group Study (E3893)#

Skeel, R. T., Huang, J., Manola, J., Wilding, G., Dreicer, R., Walker, P., Muggia, F., Crawford, E. D., Dutcher, J. P. & Loehrer, P. J., 2003, In : Cancer Investigation. 21, 1, p. 41-46 6 p.

Research output: Contribution to journalArticle

15 Scopus citations

A phase II study of 2-methoxyestradiol nanocrystal colloidal dispersion alone and in combination with sunitinib malate in patients with metastatic renal cell carcinoma progressing on sunitinib malate

Bruce, J. Y., Eickhoff, J., Pili, R., Logan, T., Carducci, M., Arnott, J., Treston, A., Wilding, G. & Liu, G., Apr 2012, In : Investigational New Drugs. 30, 2, p. 794-802 9 p.

Research output: Contribution to journalArticle

51 Scopus citations

A Phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer

Miller, K. D., Soule, S. E., Haney, L. T. G., Guiney, P., Murry, D. J., Lenaz, L., Sun, S. L. & Sledge, G. W., Jan 2004, In : Investigational New Drugs. 22, 1, p. 69-73 5 p.

Research output: Contribution to journalArticle

14 Scopus citations

A phase II study of carboplatin plus gemcitabine in advanced non-small- cell lung cancer (NSCLC): A hoosier oncology group study

Ng, E. W., Sandler, A. B., Robinson, L. & Einhorn, L. H., Dec 1 1999, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 22, 6, p. 550-553 4 p.

Research output: Contribution to journalArticle

34 Scopus citations

A phase II study of combined VEGF inhibitor (bevacizumab+sorafenib) in patients with metastatic breast cancer: Hoosier Oncology Group Study BRE06-109

Mina, L. A., Yu, M., Johnson, C., Burkhardt, C., Miller, K. D. & Zon, R., Oct 2013, In : Investigational New Drugs. 31, 5, p. 1307-1310 4 p.

Research output: Contribution to journalArticle

24 Scopus citations

A phase II study of Gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: A hoosier oncology group study

Cardenes, H. R., Moore, A. M., Johnson, C. S., Yu, M., Helft, P., Chiorean, E. G., Vinson, J., Howard, T. J., Stephens, A. W., Tai, D. F. & Loehrer, P. J., Oct 1 2011, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 34, 5, p. 460-465 6 p.

Research output: Contribution to journalArticle

43 Scopus citations

A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer

Burstein, H. J., Storniolo, A. M., Franco, S., Forster, J., Stein, S., Rubin, S., Salazar, V. M. & Blackwell, K. L., Jun 1 2008, In : Annals of Oncology. 19, 6, p. 1068-1074 7 p.

Research output: Contribution to journalArticle

180 Scopus citations

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007

Miller, K. D., Althouse, S. K., Nabell, L., Rugo, H., Carey, L., Kimmick, G., Jones, D. R., Merino, M. J. & Steeg, P. S., Oct 14 2014, In : Breast Cancer Research and Treatment. 148, 1, p. 99-106 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

A phase II study of methylphenidate for the treatment of fatigue

Hanna, A., Sledge, G., Mayer, M. L., Hanna, N., Einhorn, L., Monahan, P., Daggy, J. & Bhatia, S., Mar 2006, In : Supportive Care in Cancer. 14, 3, p. 210-215 6 p.

Research output: Contribution to journalArticle

59 Scopus citations

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen

Mina, L., Krop, I., Zon, R. T., Isakoff, S. J., Schneider, C. J., Yu, M., Johnson, C., Vaughn, L. G., Wang, Y., Hristova-Kazmierski, M., Shonukan, O. O., Sledge, G. W. & Miller, K. D., Dec 2009, In : Investigational New Drugs. 27, 6, p. 565-570 6 p.

Research output: Contribution to journalArticle

14 Scopus citations

A phase II study of pemetrexed as second-line chemotherapy for the treatment of metastatic castrate-resistant prostate cancer (CRPC); Hoosier Oncology Group GU03-67

Hahn, N. M., Zon, R. T., Yu, M., Ademuyiwa, F. O., Jones, T., Dugan, W., Whalen, C., Shanmugam, R., Skaar, T. & Sweeney, C. J., Dec 4 2009, In : Annals of Oncology. 20, 12, p. 1971-1976 6 p.

Research output: Contribution to journalArticle

16 Scopus citations

A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma

Gbolahan, O. B., Porter, R. F., Salter, J. T., Yiannoutsos, C., Burns, M., Chiorean, E. G. & Loehrer, P. J., Dec 2018, In : Journal of Thoracic Oncology. 13, 12, p. 1940-1948 9 p.

Research output: Contribution to journalArticle

7 Scopus citations

A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies

Gubens, M. A., Burns, M., Perkins, S. M., Pedro-Salcedo, M. S., Althouse, S. K., Loehrer, P. J. & Wakelee, H. A., Jul 1 2015, In : Lung Cancer. 89, 1, p. 57-60 4 p.

Research output: Contribution to journalArticle

19 Scopus citations

A phase II study of single agent gemcitabine in relapsed or refractory follicular or small lymphocytic non-Hodgkin lymphomas: A hoosier oncology group study

Ganjoo, K. N., Robertson, M. J., Fisher, W., Jung, S. H., McClean, J., Huh, S. Y., Bufill, J., Williams, S. & Cripe, L. D., Apr 1 2005, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 28, 2, p. 169-172 4 p.

Research output: Contribution to journalArticle

7 Scopus citations

A phase II study of trastuzumab emtansine in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer who were previously treated with trastuzumab, lapatinib, an anthracycline, a taxane, and capecitabine

Krop, I. E., LoRusso, P., Miller, K. D., Modi, S., Yardley, D., Rodriguez, G., Guardino, E., Lu, M., Zheng, M., Girish, S., Amler, L., Winer, E. P. & Rugo, H. S., Sep 10 2012, In : Journal of Clinical Oncology. 30, 26, p. 3234-3241 8 p.

Research output: Contribution to journalArticle

238 Scopus citations

A phase II study of weekly gemcitabine and paclitaxel in patients with previously untreated stage IIIb and IV non-small cell lung cancer

Bhatia, S., Hanna, N., Ansari, R., Pletcher, W., Einhorn, L., Ng, E. & Sandler, A., Oct 1 2002, In : Lung Cancer. 38, 1, p. 73-77 5 p.

Research output: Contribution to journalArticle

36 Scopus citations

A phase II study of weekly oral methotrexate and zidovudine (AZT) in advanced adenocarcinoma of the pancreas and hepatocellular carcinoma

Miller, K. D., Loehrer, P. J., Gonin, R., Weber, G., Ansari, R., Pletcher, W., McClean, J., Spiridonidis, C. H. & Mortimer, J., 1996, In : Investigational New Drugs. 14, 2, p. 207-212 6 p.

Research output: Contribution to journalArticle

7 Scopus citations

A Phase II study with cetuximab and radiation therapy for patients with surgically resectable esophageal and GE junction carcinomas: Hoosier oncology group G05-92

Becerra, C. R., Hanna, N., Mccollum, A. D., Becharm, N., Timmerman, R. D., Dimaio, M., Kesler, K. A., Yu, M., Yan, T. & Choy, H., Nov 2013, In : Journal of Thoracic Oncology. 8, 11, p. 1425-1429 5 p.

Research output: Contribution to journalArticle

16 Scopus citations

A Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with hormone-refractory metastatic prostate cancer

Heath, E. I., Hillman, D. W., Vaishampayan, U., Sheng, S., Sarkar, F., Harper, F., Gaskins, M., Pitot, H. C., Tan, W., Ivy, S. P., Pili, R., Carducci, M. A., Erlichman, C. & Liu, G., Dec 1 2008, In : Clinical Cancer Research. 14, 23, p. 7940-7946 7 p.

Research output: Contribution to journalArticle

137 Scopus citations